Ra Medical Systems Inc. (RMED)
AMEX: RMED
· Real-Time Price · USD
0.59
0.05 (9.26%)
At close: Aug 17, 2023, 10:00 PM
Company Description
Ra Medical Systems, Inc., a medical device company, develops, manufactures, and markets excimer lasers for use in the treatment of vascular immune-mediated inflammatory diseases.
It offers destruction of arteriosclerotic blockages by laser radiation ablation, a minimally invasive excimer laser and single-use catheter system that is used by physicians in the endovascular treatment of vascular blockages resulting from lower extremity vascular disease.
The company sells its products primarily through distributors in the United States.
Ra Medical Systems, Inc. was incorporated in 2002 and is headquartered in Carlsbad, California.
Ra Medical Systems Inc.

Country | United States |
IPO Date | Sep 27, 2018 |
Industry | Medical - Devices |
Sector | Healthcare |
Employees | 14 |
CEO | David A. Jenkins |
Contact Details
Address: 2070 Las Palmas Drive Carlsbad, California United States | |
Website | https://www.ramed.com |
Stock Details
Ticker Symbol | RMED |
Exchange | AMEX |
Fiscal Year | January - December |
Reporting Currency | USD |
CIK Code | 0001716621 |
CUSIP Number | 74933X104 |
ISIN Number | US74933X1046 |
Employer ID | 38-3661826 |
SIC Code | 3841 |
Key Executives
Name | Position |
---|---|
David A. Jenkins | Executive Chairman & Interim Chief Executive Officer |
Jonathan Will McGuire | Chief Executive Officer & Director |
Brian D. Conn | Interim Chief Financial Officer |
Steven K. Passey CPA | Chief Financial Officer & Sec. |
Al Memmolo B.S. MBA | Senior Vice President of Clinical, Quality & Regulatory Affairs |
Maria Villanueva | Vice President & Compliance Officer |
Tiah Reppas | Vice President, Chief Accounting Officer & Corporation Controller |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Aug 14, 2025 | SCHEDULE 13G/A | [Amend] Filing |
Aug 14, 2025 | 4 | Filing |
Aug 14, 2025 | 4 | Filing |
Aug 14, 2025 | 4 | Filing |
Aug 14, 2025 | 4 | Filing |
Aug 11, 2025 | 10-Q | Quarterly Report |
Aug 11, 2025 | 8-K | Current Report |
Aug 07, 2025 | 424B5 | Filing |
Jul 28, 2025 | 8-K | Current Report |
Jun 26, 2025 | S-8 | Filing |